Cycloserine contraindications: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Cycloserine}} {{CMG}} ; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SEROMYCIN (CYCLOSERINE) CAPSULE [PURDUE GM...")
 
No edit summary
Line 4: Line 4:




==CONTRAINDICATIONS SECTION==


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = SEROMYCIN (CYCLOSERINE) CAPSULE [PURDUE GMP CENTER LLC DBA THE CHAO CENTER] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e1e08327-4b90-463e-bb2a-22438cabcef2 | publisher =  | date =  | accessdate  }}</ref>
Administration is contraindicated in patients with any of the following:
 
Hypersensitivity to cycloserine
 
Epilepsy
 
Depression, severe anxiety, or psychosis
 
Severe renal insufficiency
 
Excessive concurrent use of alcohol<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = SEROMYCIN (CYCLOSERINE) CAPSULE [PURDUE GMP CENTER LLC DBA THE CHAO CENTER] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e1e08327-4b90-463e-bb2a-22438cabcef2 | publisher =  | date =  | accessdate  }}</ref>





Revision as of 17:40, 26 December 2013

Cycloserine
SEROMYCIN ® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]


CONTRAINDICATIONS SECTION

Administration is contraindicated in patients with any of the following:

Hypersensitivity to cycloserine

Epilepsy

Depression, severe anxiety, or psychosis

Severe renal insufficiency

Excessive concurrent use of alcohol[1]


References

  1. "SEROMYCIN (CYCLOSERINE) CAPSULE [PURDUE GMP CENTER LLC DBA THE CHAO CENTER]". Text " accessdate " ignored (help)

Adapted from the FDA Package Insert.